Skip to main content
BMJ Open logoLink to BMJ Open
. 2020 Sep 3;10(9):e037036. doi: 10.1136/bmjopen-2020-037036

Intermittent pneumatic compression for venous thromboembolism prevention: a systematic review on factors affecting adherence

Richard Greenall 1,, Rachel E Davis 2
PMCID: PMC7473613  PMID: 32883726

Abstract

Objective

Venous thromboembolism (VTE) is a potentially fatal complication of hospitalisation. Intermittent pneumatic compression (IPC) is one approach to reducing the likelihood of a VTE. Adherence to IPC is known to be inadequate though the reasons for this remain unclear. This systematic review explores factors that affect adherence to IPC in the inpatient context.

Methods

Information sources—EMBASE, MEDLINE and PsycINFO were searched for literature between January 1960 and May 2019. Eligibility criteria—studies were included if they focused on inpatient care and examined factors affecting adherence to IPC devices.

Results

Included studies—a total of 20 out of 1476 studies were included. Synthesis of results—eight factors were identified that affected adherence: patient discomfort (n=8), healthcare professionals’ knowledge and behaviours (n=6), mobilisation (n=6), equipment supply and demand (n=3), the use of guidelines (n=3), intensive care context (n=2), computer-assisted prescribing (n=2) and patients’ knowledge of IPC (n=1).

Conclusion

Overall while the evidence base is quite limited, a number of factors were shown to affect adherence to IPC. These findings could be used to inform future research and quality improvement efforts to increase adherence in this very important, but currently under-researched area.

Keywords: thromboembolism, bleeding disorders & coagulopathies, quality in health care


Strengths and limitations of this study.

  • First known review of the evidence affecting adherence to intermittent pneumatic compression (IPC).

  • Eight factors were identified that resulted in measurable changes to adherence to IPC.

  • Results largely based on direct observation rather than self-report.

  • Studies generally had low sample sizes.

  • Studies with different aims and methodologies were included.

Background

Venous thromboembolism (VTE) is a term that most commonly refers to deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE affects one in 1000 people annually1 and in England in 2018 VTE was recorded as a cause of death in 12 000 cases.2 Compared with baseline risk, hospitalisation has been correlated with an eightfold increased risk of VTE in medical admissions and a 21-fold increased risk in surgical admissions3 with one study estimating that up to 50% of 625 cases of VTE in the community were related to hospitalisation.4 Secondary to adverse drug events, VTE is the leading complication of hospitalisation worldwide.5

The financial cost of hospital-associated VTE is high. In 2017, a UK survey revealed the average cost of treating VTE was £938 357 for each local National Health Service (NHS) region.6 At a patient level, a review7 identified an increase in cost of $14 000 for initial diagnosis and the first year of treatment for those with VTE compared with non-VTE affected patients. VTE can have a significant impact on a person’s psychosocial well-being with research to suggest that it can be a traumatic, life-changing event which can lead to post-traumatic stress disorder.8 9

Since hospitalisation increases the risk of VTE, it is important to consider if anything can be done to reduce the risk within this context. In England, the national VTE prevention programme combined a mandate for assessment of patient’s risk on admission to hospital with best practice prevention guidelines. Early results indicate that its efforts have led to reduced morbidity and mortality.10 Similar efforts have been made in the USA11 and throughout Europe, recent evidence indicates that better management of the risk of VTE has reduced VTE-related mortality from 12.8 to 6.5 deaths per 100 000.12

Risk assessing all patients on admission to hospital leads to identification of patients at high risk who need thromboprophylaxis (ie, treatments to prevent VTE). In the UK, national guidelines13 advise using the chemical thromboprophylaxis low molecular weight heparin for most groups of at-risk hospitalised patients. Mechanical thromboprophylaxis is advised for most surgical patients and other high-risk groups, such as patients with stroke. Graduated compression stockings (GCS) are one type of mechanical intervention. GCS exerts graded pressure around the legs, increasing the speed of blood flow and reducing the opportunity for VTE to form.14

Intermittent pneumatic compression (IPC) is another type of mechanical device. Fabric sleeves that wrap around a patient’s legs are attached to a pump using a tube and are periodically inflated and deflated. IPC is thought to reduce VTE by increasing the speed of blood flow and reducing hypercoagulability through the IPC action stimulating the vessel walls fibrinolytic activity.15 16 Evidence demonstrates that combining IPC and GCS decreases the incidence of VTE to a greater effect than either separately.17 Systematic reviews found the same increased effect when combining IPC and pharmacological prophylaxis18 and that IPC can reduce the incidence of VTE in surgical patients.19 However, despite these benefits, research has shown considerable variability in adherence to IPC device use, with a systematic review of seven studies in acute hospitals reporting a median adherence rate of 78% (range 40%–89%).20 The authors concluded that strategies to improve adherence are needed but the question remains as to why non-adherence occurs.

While factors affecting adherence have been reviewed within surgical specialities,19 to the best of our knowledge, no attempt has been made to comprehensively investigate the factors that could facilitate or impede adherence to IPC across all specialities. This paper aims to address this important gap in the evidence base by systematically reviewing the factors that influence adherence to IPC for VTE prevention in acute care. Gaining this understanding is critical in order to develop interventions, strategies and policies that are accurately targeted at meeting the challenges of improving adherence.21

Methods

Patient and public involvement

No patient was involved.

Search strategy

EMBASE, MEDLINE and PsycINFO were searched for relevant literature published between January 1960 and May 2019. The search strategy comprised terms relating to: (1) population (eg, ‘IPC’); (2) intervention (eg, ‘strategies’) and (3) outcomes (eg, ‘adherence’). The search was customised to each database and restricted to titles and abstracts to tighten its specificity. A sensitivity analysis was performed to ensure that the search results included key articles identified through an initial scoping review. Forward and backward citation searching and hand searching of key journals were performed to minimise the likelihood of missing relevant papers. The final search was conducted on 30 May 2019 (for the full search strategy please refer to online supplementary file 1).

Supplementary data

bmjopen-2020-037036supp001.pdf (70.6KB, pdf)

Inclusion criteria

Based on UK national guidelines that were current at the time of this review’s development (January 2018),13 the definition of IPC in this review includes only devices that are applied to the legs and excludes foot compression devices. The first stage of screening (title and abstract) was intentionally inclusive and retained any empirical articles that mentioned adherence to IPC in any context. In the second stage (full text), tighter restrictions applied. Articles were included if they reported barriers or facilitators to adherence to IPC in the inpatient context and included a measure of the effect (percentage change in adherence to IPC) of such factors on adherence (either as a primary or secondary aim or an indirect finding in the results). Dissertations and doctoral theses, books, book reviews, conference posters and presentations, editorials and commentaries were excluded, as were articles not published in English or those focused on patients under 18 years of age. Review/commentary papers that addressed adherence to IPC20 were examined for relevant empirical papers but the reviews themselves were excluded.

Study selection and data extraction

Articles were screened for relevance by the lead author (RG). The second author (RED) screened 20% of the articles at abstract stage and 100% at full-text stage. Discrepancies were resolved through joint discussion between the authors. Dual data extraction of the included articles was conducted independently by both authors and then checked for consistency. We did not predetermine the factors that could affect adherence to IPC. Rather, we reviewed the data in each article and then grouped these into categories of factors that could affect adherence to IPC. These factors were decided initially by the first author (RG) and then checked by the second author (RED). Disagreements were resolved by joint discussion until consensus was reached.

Quality assessment

While numerous scales are available to assess the methodological quality of studies, these are often restricted to specific study designs, including randomised controlled trials (RCTs)22; case–control and cohort studies23 and qualitative studies.24 Given our review included articles that employed heterogeneous study designs and differing aims, we did not use a quality assessment scale, nor did we deem this meaningful. We did, however, consider differences in the methodologies that could potentially bias the findings to enable greater understanding of the relative strengths and weaknesses of the research. To gain a comprehensive understanding of the full body of evidence, we did not exclude articles based on their methodological quality.

Results

Study selection

Of 1476 articles retrieved, 1324 were excluded at the first stage of screening (title/abstract) and 132 (out of the remaining 152) were excluded after full-text screening, resulting in 20 articles. Two of the included articles were added through handsearching25 26 (see figure 1). On examination, these studies were missed in the initial search due to the use of the word ‘external’ instead of ‘intermittent’ to describe pneumatic compression. Further scoping the literature (using the term ‘external’) revealed there were no other additional articles that needed to be included.

Figure 1.

Figure 1

Preferred reporting items for systematic reviews and meta-analyses flowchart of search results retrieved on 30 May 2019.

Characteristics of included studies

Articles were published between 1992 and 2018 across six countries, including the USA (n=1525–39), Spain (n=140), Japan (n=141), Canada (n=142), France (n=117) and Brazil (n=143). Characteristics of patients and care locations included critical care,17 26 29 40 41 general surgical wards28 33–35 38 42 43 and gynaecology25 36 37 39 specialties. Factors affecting adherence to IPC was the primary focus of 13 studies.25 27–34 36 37 39 40 A further seven studies17 26 35 38 41–43 focused on IPC device safety and effectiveness in preventing VTE but also reported barriers or facilitators to IPC adherence. Seventeen of the studies were observational,26–41 43 using surveys and clinical observations as investigation tools. The remaining three studies were RCTs.17 25 42 Due to wide heterogeneity in study methodologies, meta-analysis was not possible. Table 1 details the characteristics of the included studies.

Table 1.

Characteristics of included studies

Author Study design Setting Studies main objective Focus was adherence barriers/facilitators? Sample size Participants (mean age) Country
Bockheim et al29 Prospective observational Critical care and ward care Comparison of IPC compliance between ICU and non-ICU areas Yes 150 Female 73, Male 77 (62) USA
Brady et al30 Prospective observational Acute nursing care wards To assess comfort and fit and compliance of knee versus thigh length IPC Yes 137 Female 72, Male 65 (55) USA
Brady et al39 Prospective observational Caesarean or gynaecological surgery To assess impact of education on compliance to IPC Yes 228 Female 59 (38) USA
Chen et al37 Prospective observational Obstetrics Assess the effectiveness of an intervention in improving compliance to IPC Yes 76 Female 76 (28) USA
Cindolo et al31 Prospective observational Radical retropubic prostatectomy surgery To assess acceptability and satisfaction to IPC Yes 184 Male 184 (69) USA
Comerota et al26 Prospective observational Critical care and ward care Comparison of IPC compliance between ICU and non-ICU areas No 138 Not reported USA
Cornwell et al38 Prospective observational Surgical trauma To assess compliance of IPC in trauma patients No 227 Female 39, Male 188 (37) USA
Elphern et al32 Prospective observational Critical care Identifying reasons for errors in the application of IPC Yes 123 Female 42, Male 54 USA
García-Olivares et al40 Prospective observational Critical care Factors associated with inadequate thromboprophylaxis in critically ill patients Yes 777 Female 270, Male 507 (61) Spain
Gardiner & Kelly33 Prospective observational Surgical wards Quality improvement to increase IPC compliance Yes 339 Not reported USA
Kim et al27 Cohort study Surgical, medical and critical care Accuracy of VTE assessment, compliance to IPC and effect of education on compliance Yes 200 Female 97, Male 103 (62) USA
Maffei et al43 Retrospective observational Surgical wards Before and after study of implementation of thromboprophylaxis guidelines No 150 Female 77, Male 73 (64) Brazil
Maxwell et al25 Randomised controlled trial Surgical gynaecology To assess preference and compliance in patients receiving heparin and IPC Yes 104 Female 104 (61) USA
Novis et al34 Prospective observational Surgical wards Utilisation of DVT prophylaxis after implementation of electronic risk assessment Yes 800 Female 15, Male 785 (64) USA
Obi et al35 Prospective observational Surgical wards Comparison of compliance with a standard versus battery powered IPC device No 67 Female 32, Male 35 (51) USA
Palmerola et al36 Prospective observational Obstetrics Compliance with IPC after caesarean delivery Yes 293 Female 293 (32) USA
Ritsema et al28 Observational Surgical wards Study of the influence of hospital and patient factors on compliance Yes 100 Female 24, Male 76 USA
Sobierag-Teague et al42 Randomised controlled trial Neurosurgery Trialling the efficacy and tolerability of an IPC device No 75 Female 31, Male 44 (62) Canada
Vignon et al17 Randomised controlled trial Critical care Effectiveness of compression stockings with and without IPC No 205 Female 72, Male 132 (55) France
Yamamoto et al41 Prospective observational Critical care Exploring the current practice of VTE prevention in Japanese ICUs No 470 Female 168, Male 302 (65) Japan

DVT, deep vein thrombosis; ICU, intensive care unit; IPC, intermittent pneumatic compression; VTE, venous thromboembolism.

Factors affecting adherence to IPC

Articles varied considerably in the level of content and detail provided regarding study designs and adherence to IPC. We report the main findings here and provide a more detailed analysis of findings for studies where this was possible. Table 2 outlines the eight factors that were identified that affected adherence to IPC.

Table 2.

Factors affecting adherence

Author Factors Findings
Bockheim et al29 Intensive care context ICU has greater compliance than non-ICU
Brady et al30 Patient discomfort Cause of non-adherence was; 39% discomfort
Mobilisation 46% had just ambulated
Healthcare professional knowledge and behaviours 13% the nurse had not reapplied the IPC after transfer from another unit
Brady et al39 Healthcare professional knowledge and behaviours When asked, 23% of patients said nurses instruction to not wear
Equipment supply and demand 13% did not have part of the device in the room
Mobilisation 17% said they had just returned to bed, 16% walking around, 7% just about to walk around
Patient discomfort 15% of patients said the IPC was uncomfortable
Chen et al37 Computer-assisted prescribing A pre-checked electronic order increased prescribing adherence from 46% to 77%
Cindolo et al31 Patient discomfort Noise and insomnia were reported as being a negative experience in 23% and 44% of cases, respectively. Authors state these issues were reasons why 3% had IPC removed early
Comerota et al26 Intensive care context ICU has greater compliance than non-ICU
Cornwell et al38 Healthcare professional knowledge and behaviours Compliance rate of 53%. Information reported about non-compliance was that the device was not in place (95%)
Elpern et al32 Healthcare professional knowledge and behaviours In 51% of non-adherence observed, IPC sleeves were not correctly applied and 24% the machine was not switched on
García-Olivares et al40 Mobilisation Patients with invasive mechanical ventilation and complete bedrest had greater compliance
Guidelines use of a protocol and risk scoring system led to decreased risk of inappropriate VTE prophylaxis
Gardiner et al33 Equipment supply and demand In 38% of non-adherent cases the IPC machine was not in the room, locating IPC machines in rooms resulted in adherence from 26% to 44%
Healthcare professional knowledge and behaviours A nursing knowledge and beliefs survey yields information about barriers that nurses bring to the use of IPC
Kim et al27 Knowledge 40% overall non-adherence to IPC. Of these, 40% said that no one informed them they needed to keep IPC on
Patient discomfort 40% overall non-adherence to IPC, 33% said this was due to discomfort
Maffei et al43 Guidelines After guidelines were introduced, IPC prescription increased from 26% to 32%
Maxwell et al25 Healthcare professional knowledge and behaviours Of 736 observations, non-compliance was noted in 2.7% of cases and this was related to the machine not being switched on
Novis et al34 Computer-assisted prescribing Electronic suggestion of thromboprophylaxis increased the use of IPC from 50% to 63%
Obi et al35 Device related A battery powered device facilitated adherence through enabling mobilisation
Patient discomfort A new machine design led to fewer reports of patient discomfort (33% vs 13%)
Mobilisation Problems with mobilisation were less using a new machine (71% vs 29%)
Palmerola et al36 Mobilisation 38% of patients classed as non-adherent to IPC therapy had it discontinued due to liberal standards for ambulation
Ritsema et al28 Mobilisation Not replaced after mobilising accounted for 50% of non-compliant observations
Equipment supply and demand Lack of machine or cuffs accounted for 22% of non-adherence
Patient discomfort Patient discomfort accounted for 19% of non-adherence
Sobierag-Teague et al42 Patient discomfort 48% of users discontinued the device at night. Comfort-related issues discussed but not explicitly linked to non-adherence
Vignon et al17 Patient discomfort 7% non-compliance in the AES+IPC group. IPC was discontinued due to discomfort, noise and restlessness
Yamamoto et al41 Guidelines Combined AES and IPC mechanical prophylaxis was higher in units with a protocol than without (88% vs 80%)

AES, anti-embolic stockings; ICU, intensive care unit; IPC, intermittent pneumatic compression; VTE, venous thromboembolism.

Patient discomfort

Patient discomfort associated with wearing the IPC device was identified in eight studies.17 27 28 30 31 35 39 42 Vignon et al17 identified poor adherence in 7% (14/204) of patients due to discomfort, noise and restlessness. Brady et al30 observed the effect of the length of the IPC sleeve on comfort and subsequent non-adherence. Overall adherence was 29% (40/137) based on a one-off observation. Eighty-five per cent of non-adherent users had been wearing thigh length (53%) or knee length (32%) sleeves. Discomfort was reported as a reason for non-adherence by 39% (58/149) of patients who were non-adherent. Those wearing thigh length sleeves reported double the number of complaints compared with those wearing knee length sleeves (39 vs 15).

Brady et al39 examined adherence over several days postoperatively. Taking multiple observations of the same patients, adherence was 75% (43/57) on day 0, 53% (148/278) on day 2 and 44% (11/25) on day 4. Patients who were non-adherent were asked why at the time of observation and 15% (53/362 responses) stated discomfort as a reason. Kim et al27 compared two groups of 100 patients in a multifaceted improvement strategy to increase adherence to IPC. Post intervention a slight improvement was achieved (24% vs 26%). Ninety-two per cent (58/63) of nurses and 29% (4/14) of non-adherent patients reported discomfort as a reason for the lack of adherence.

Ritsema et al28 found that patients were non-adherent 21% of the time (98/457 observations) with patient interviews indicating that discomfort was a reason in 19% (19/100) of responses. Sobieraj-Teague et al42 trialled the efficacy of a newly developed IPC machine which allowed the patient to mobilise independently of a power cable through the utilisation of batteries and small product design. Poor adherence was found in 49% (35/72) of users, in particular at night, with patients reported they discontinued therapy due to insomnia. Similar findings, but to a much lesser extent, were reported by Cindolo et al31 when evaluating the comfort and tolerability of a specific IPC device. While non-adherence was only 3% (6/184), patients who requested discontinuation of IPC therapy did so due to noise and insomnia.

A final study by Obi et al35 was designed as a retrospective review examining whether a different design of IPC device would reduce non-adherence. Comparing a standard machine to a new machine, adherence to the standard machine was 47% vs 85% for the newer machine. Of responses from those patients wearing the standard compared with the new machine (21 and 24, respectively), problems with discomfort as reported less (33% vs 13%).

Healthcare professional (HCP) knowledge and behaviours

Failure of healthcare professionals to apply or provide IPC when prescribed was identified in six studies.25 30 32 33 38 39 Brady et al30 found that 16% (12/73) of survey respondents reported that the nurse had never initiated IPC therapy or had not replaced the sleeves after transfer of the patient from another location. Brady et al39 found that 23% (82/356) of non-adherent patients stated the nurse had informed them that they did not require IPC anymore.

Cornwell et al38 observed adherence of 53% (out of 712/1343 observations of 233 patients). The authors reported that this was because the device was ‘not in place’. The time of day that non-adherence was most frequently noted was in the early afternoon and the authors concluded that it is both healthcare professionals (HCPs) and patients who need to be educated about the importance of wearing IPC as the patient may have been the one who removed it.

Elpern et al32 reported that errors in the application of IPC therapy were identified in 49% (477/966) of observations of a cohort of 123 patients. In 244 observations, the sleeves were incorrectly applied to the patient and in 116 observations, the pump was not turned on. Similar findings by Maxwell et al25 in 104 patients identified that the reason for non-adherence in 3% (20/736) of observations was that the IPC was not turned on. Gardiner et al33 reported that only 26% (89/339) of patients were adherent to IPC on initial audit. A survey of nursing beliefs, practice and knowledge determined that part of the problem was deficiencies in nursing knowledge. Education interventions as well as placing IPC machines in individual rooms of patients improved adherence from 26% to 44%.

Mobilisation

Issues relating to mobilisation were identified as factors affecting adherence in six studies.28 30 35 36 39 40 Brady et al30 found that of 149 responses from non-adherent patients, 46% (68/149) of patients reported that they had just mobilised. Similarly, Brady et al39 found that 16% (59/362) of patients reported that they had just been walking around, 17% (62/362) stated they had just returned to bed and 7% (24/362) were just about to walk around. In a study by Ritsema et al28 previously discussed in relation to patient discomfort, patients identified that not replacing the IPC sleeves after mobilisation was a cause of non-adherence in 50% of 98 non-adherent episodes observed.

Palmerola et al36 found adherence to IPC after caesarean delivery was 79.5% (233/293). Of the 60 non-adherent patients, 62% (37/60) had the IPC machine and sleeves in the room but they were not applied and 38% (23/60) had it discontinued due to ‘liberal standards for mobilisation’. A study by Obi et al35 previously discussed in relation to ‘patient discomfort’ found that problems with mobilising were reported less using a new machine compared with a standard one (71% vs 29%). García-Olivares et al40 found that complete bed rest for >2 days resulted in improved appropriateness of prophylaxis (OR 0.6) with similar findings reported for mechanical ventilation (OR 0.7).

Equipment supply and demand

Three studies28 33 39 highlighted that equipment supply and demand could affect adherence. Brady et al39 identified that part of the IPC device was not present in the room in 13% (49/362) of non-adherent episodes although reasons why were not explored. Similar findings by Ritsema et al28 found that the second most commonly reported reason for non-adherence was no machine or sleeves being available to the patient (22/100 questionnaire responses). As previously discussed within ‘healthcare professionals knowledge and behaviours’, a study by Gardiner et al33 revealed that of 250 patients who were non-adherent, 39% (97/250) did not have part of the equipment in the room. This same study found that adherence increased from 26% to 44% through an educational intervention and making IPC machines widely available instead of difficult to obtain for use.

Guidelines

The use of guidelines for VTE prevention was identified as a factor that could affect adherence in three studies.40 41 43 García-Olivares et al40 used an electronic questionnaire to investigate inappropriateness of VTE prophylaxis (all types) on a single day across multiple intensive care units (ICUs). A total of 777 patients across 73 ICUs were included: the use of a protocol reduced inappropriate VTE prevention prescribing (OR 0.6) as well as a VTE risk scoring system (OR 0.4). Yamamoto et al41 obtained data from 99 ICUs and included 470 patients in their analysis. Hospitals using protocols had higher rates of prophylaxis provision than those who did not (89% vs 80%) and this difference was mainly due to the increase in the combined use of anti-embolic stockings (AES) and IPC (26% vs 15%). A similar effect was demonstrated by Maffei et al43 who retrospectively analysed the accuracy of prescribing of VTE prophylaxis after the implementation of guidelines. Compared with before the implementation of guidelines, prescribing of IPC therapy increased from 26% to 32% after.

Intensive care context

Care provision in the ICU context was identified by two studies as having an impact on adherence.26 29 Comerota et al26 examined 138 patients and found that adherence in the ICU setting was higher than elsewhere in the hospital (78% vs 48%) but did not investigate reasons for this. A study by Bockheim et al29 found adherence in the ICU context was 69% (52/75) compared with 40% (30/75) outside of the ICU. The authors concluded the reasons for this were likely to be multifactorial they did not empirically determine what these factors might be.

Computer-assisted prescribing

Computer-assisted prescribing was reported as a factor affecting adherence in two studies.34 37 Chen et al37 examined the long-term impact of automatic pre-orders for IPC on an electronic prescription system. Prior to the intervention, prescribing of IPC was carried out on 46% (denominator not reported) of patients. One year later, this had increased to 78% (59/76). IPC was only present in 71% (42/59) of patients who had been prescribed IPC and was only being used by 45% (19/42) of those patients. The authors concluded that the intervention had successfully increased prescribing of IPC but not overall adherence.

Novis et al34 used a similar approach but did not assess the impact of adherence to IPC at a patient level. Computer-generated suggestions of preoperative prophylaxis were provided to the clinician as a result of information entered about the risk of VTE to the patient. The result was a 40% increase in prescribing of IPC from 215 to 301 patients with an active prescription.

Patient knowledge

A study by Kim et al27 concluded that the information needs of patients were a factor affecting adherence. An initial survey found that 59% (32/54) of patients did not have IPC applied when prescribed. Several clinician-focused interventions were conducted, and a survey of patients a year later found that 62% (41/66) of patients requiring IPC therapy did not have it applied. From this, 30% (11/37) of patients reported that they did not know what a DVT is and 62% (23/37) reported that they had not been educated about IPC. The authors conclude that a lack of education is an important barrier to adherence, however, evidence to demonstrate that increasing education results in improved adherence was not presented.

Quality assessment

Seventeen26–41 43 (out of the 20) articles included in the review were observational in nature. All of these studies (n=17) measured adherence to IPC by direct observation of researchers rather than based on self-report, which could have been subject to recall bias. Eight of these studies measured adherence twice daily,25 26 28 29 33 37 39 42 three had a single observation point (the first day postoperatively31 36 and not reported30), one35 had hourly monitoring across a 24 hours period and one17 did not report when they observed adherence, only that they did this. In addition to direct observations, data on factors affecting adherence using patient surveys were performed in eight studies17 25 27 28 30 31 39 42 and indirect indicators such as the effect of a change in device type or the result of a guideline implementation was used in seven studies.26 29 34 35 37 43 The three RCTs17 25 42 collected data on adherence using researcher observations and patient surveys.

Over half of the articles25 27–34 36 37 39 40 (n=13) focused on factors affecting adherence to IPC as a primary outcome. The remaining studies17 26 35 38 41–43 (n=7) investigated as the safety and effectiveness of IPC as their main outcome. As a result of these investigations, these studies also provided data on factors affecting adherence (though this was not their aim). It is difficult to determine whether additional factors may have been uncovered from these studies (ie, that are not reported in our findings) if the authors had specifically set out to examine how adherence to IPC could be affected. Taken collectively, the patient sample sizes for each study ranged from between 67 (35) to 800 (34) with the majority of studies being based on over 100 patients. Articles we included were published across a 27-year period.

Discussion

This paper presents the findings of a systematic review on factors affecting adherence to IPC in the inpatient setting. In total eight factors were identified that affected adherence, with patient discomfort related to wearing the IPC device being most commonly reported and issues related to computer-assisted prescribing and patients’ knowledge of IPC being the least frequently reported. The majority of factors delineated (such as patient discomfort, mobilising, healthcare professional knowledge and behaviours, patient knowledge, equipment supply and demand) acted as a barrier to adherence to IPC. However, some evidence points to specific facilitators of adherence (eg, the use of guidelines and protocols and computer-assisted prescribing).

There are several important implications of this work. First, discomfort with the IPC device was a considerable cause for non-adherence. The development and/or use of new or alternative IPC devices should be considered when addressing adherence issues. Research has demonstrated that using methods to systematically incorporate the user perspective early in the design process can result in the development of a device which is safe, effective and used by the patient.44 Research more widely in the field that examined the use of a modern IPC device demonstrates that it is possible to develop comfortable devices45 with 86% (26/30) of patients reporting it was comfortable and that they would use it again if required. Two studies35 42 within this review reported adherence levels when studying different machine designs and one study focused on the length of IPC sleeve30 and its effect on adherence with knee length sleeves being adhered to to a greater degree. The same study found similar results with the length of AES and this was also found in a review of adherence in surgical specialities.46 There is, therefore, scope for further research using a randomised control study design to assess widely used IPC machines, the length of sleeves and the effect both factors have on adherence, particularly in relation to comfort.

Second, and related to the above point, mobility was often reported as a barrier to adherence. One likely explanation for this could be that it was uncomfortable for patients to mobilise while wearing the device, so for this reason it was removed. Evidence26 29 from our review revealed that adherence was less of an issue for those patients that were unable to move around. However, IPC is designed to promote blood flow during immobility and if a patient is mobile, it could be concluded that IPC is no longer required and thus would not meet the criteria for data being collected as adherent or not. While this is a point that warrants further investigation, our findings suggest this could be why mobilisation (perhaps wrongly so) was identified as an adherence-related issue. Within the wider literature, a systematic review47 on the definition used for immobility within thromboprophylaxis studies concluded that a lack of consistency in the definition of immobility may contribute to the underutilisation of thromboprophylaxis in clinical practice. In our review, the definition of mobility to the extent that IPC was no longer required was not stated by any of our included studies. In place of a widely agreed consensus, an institution-wide definition of mobility could assist individual hospitals to ensure that best practice is promoted in relation to IPC adherence.

Third, we found that HCP knowledge and beliefs could contribute to non-adherence. It is not clear from our studies whether on those occasions when an IPC device was not fitted, the reasons related more to the HCP not knowing they needed to do this, whether they simply forget, or whether there has been some other unknown issue. While this warrants further investigations, there are some relatively straightforward strategies that could be put in place, based on our preliminary findings. For example, prompts and educational leaflets could be distributed on the hospital wards to remind HCPs when the use of IPC is required and why this is important. Training is essential if optimal adherence levels are to be achieved and maintained. Equally, ensuring the layout of the ward allows easy accessibility of equipment (such as IPC) is also important, particularly, given our review revealed this to be a determinant of adherence.

Finally, our review revealed that the use of guidelines and how they are incorporated into electronic prescribing systems could act as a facilitator to adherence. Similar findings (which examined, in part the use of pre-printed orders) have been reported in a review of the barriers and facilitators to adherence to chemical thromboprophylaxis48 within the ICU setting. Additional research that examined how electronic prescribing can lead to a reduction in errors, identified an absolute risk reduction of up to 30%.49 Together with the evidence in this review, it could be concluded that if IPC prescribing is included in electronic prescribing systems, improvements in adherence to guidelines may be achieved.

Strengths and limitations

There are several strengths of this review. To the best of our knowledge, this is the only paper of its kind to systematically review the evidence on factors affecting adherence to IPC across medical and surgical specialities. Wider research within the field that has reviewed the literature relating to IPC adherence found a median adherence rate of 78%.20 The review concluded that strategies to improve adherence are required. Our review helps to address this important gap in the evidence, shedding light on potential indicators of issue.

The evidence in our review was derived from articles that provided an actual measure of adherence in clinical settings and the subsequent factors that could help to explain these adherence rates. Many of the factors relating to adherence were based on direct observation rather than self-report.

A caveat to mention when interpreting our findings is that while data were based on quite a large body of evidence, there were differing (and sometimes low) sample sizes as well as different aims and methodologies and countries and settings of focus. Included studies were also spread over a long period of time (27 years), in which policies and procedures around IPC may have changed. Equally most of the factors affecting adherence were only reported a few times. While, admittedly this was not the primary aim of the studies included in our review, but rather was reported as secondary finding in relation to explaining adherence rates, further work is required to understand the relative strength of the evidence. Nonetheless, this review provides a useful first step to delineating important (and perhaps otherwise empirically unknown) factors affecting adherence to IPC. These findings could be used to help inform, implement and evaluate the use of specific strategies to overcome factors causing adherence-related issues.

Conclusion

This systematic review set out to uncover the factors that affect adherence to IPC for VTE prevention in acute care. Gaining this understanding is critical in order to develop interventions, strategies and policies which are accurately targeted at meeting the challenges of improving adherence.21 While our review has addressed an important gap in the evidence base and taken the first steps to understanding reasons why non-adherence to IPC may occur, it is clear more research is required in this area to further understand the relative strength of the evidence, so that effective strategies to overcome barriers to adherence can be sought.

Supplementary Material

Reviewer comments
Author's manuscript

Footnotes

Twitter: @kingsnurserich

Contributors: RG and RED designed the paper and were responsible for its conceptualisation. RG drafted the paper and RED edited it. Both authors were involved in the screening of the articles included in the review and have read and approved the final version of the manuscript.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. RED is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration: South London at King’s College Hospital NHS Foundation Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, NIHR, or the Department of Health and Social Care.

Competing interests: None declared.

Patient consent for publication: Not required.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data availability statement: All data relevant to the study are included in the article or uploaded as supplementary information. All data generated or analysed during this study are included in this published article (and its supplementary information files)

References

  • 1.Silverstein MD, Heit JA, Mohr DN, et al. . Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585–93. 10.1001/archinte.158.6.585 [DOI] [PubMed] [Google Scholar]
  • 2.NHS Digital 5.1 deaths from venous thromboembolism (VTe) related events within 90 days post discharge from hospital, 2019. Available: https://digital.nhs.uk/data-and-information/publications/statistical/nhs-outcomes-framework/august-2020/domain-5-treating-and-caring-for-people-in-a-safe-environment-and-protecting-them-from-avoidable-harm-nof/5-1-deaths-from-venous-thromboembolism-vte-related-events-within-90-days-post-discharge-from-hospital [Accessed 18 Oct 2019].
  • 3.Heit JA, Silverstein MD, Mohr DN, et al. . Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809–15. 10.1001/archinte.160.6.809 [DOI] [PubMed] [Google Scholar]
  • 4.Heit JA, O’Fallon WM, Petterson TM, et al. . Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002;162:1245–8. 10.1001/archinte.162.11.1245 [DOI] [PubMed] [Google Scholar]
  • 5.Jha AK, Larizgoitia I, Audera-Lopez C, et al. . The global burden of unsafe medical care: Analytic modelling of observational studies. BMJ Qual Saf 2013;22:809–15. 10.1136/bmjqs-2012-001748 [DOI] [PubMed] [Google Scholar]
  • 6.All-Party Parliamentary Thrombosis Group All-Party parliamentary thrombosis group annual review 2017, 2017. [Google Scholar]
  • 7.Grosse SD, Nelson RE, Nyarko KA, et al. . The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res 2016;137:3–10. 10.1016/j.thromres.2015.11.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Noble S, Lewis R, Whithers J, et al. . Long-term psychological consequences of symptomatic pulmonary embolism: a qualitative study. BMJ Open 2014;4:e004561. 10.1136/bmjopen-2013-004561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hunter R, Lewis S, Noble S, et al. . “Post-thrombotic panic syndrome”: A thematic analysis of the experience of venous thromboembolism. Br J Health Psychol 2017;22:8–25. 10.1111/bjhp.12213 [DOI] [PubMed] [Google Scholar]
  • 10.Roberts LN, Durkin M, Arya R. Annotation: developing a national programme for VTe prevention. Br J Haematol 2017;178:162–70. 10.1111/bjh.14769 [DOI] [PubMed] [Google Scholar]
  • 11.Maynard GA. Preventing hospital-associated venous thromboembolism: a guide for effective quality improvement. 2nd edn Rockville, MD: Agency for Healthcare Research and Quality, US Department of Health and Human Services, 2015. [Google Scholar]
  • 12.Barco S, Mahmoudpour SH, Valerio L, et al. . Trends in mortality related to pulmonary embolism in the European region, 2000-15: analysis of vital registration data from the WHO mortality database. Lancet Respir Med 2020;8:277–87. 10.1016/S2213-2600(19)30354-6 [DOI] [PubMed] [Google Scholar]
  • 13.NICE Clinical guideline 92 venous thromboembolism: reducing the risk: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism), 2010. Available: https://www.nice.org.uk/guidance/ [Accessed 11 May 2018].
  • 14.Sigel B, Edelstein AL, Savitch L, et al. . Type of compression for reducing venous stasis. A study of lower extremities during inactive recumbency. Arch Surg 1975;110:171–5. 10.1001/archsurg.1975.01360080037005 [DOI] [PubMed] [Google Scholar]
  • 15.Jacobs DG, Piotrowski JJ, Hoppensteadt DA, et al. . Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results. J Trauma 1996;40:710–7. 10.1097/00005373-199605000-00005 [DOI] [PubMed] [Google Scholar]
  • 16.Comerota AJ, Chouhan V, Harada RN, et al. . The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997;226:306–14. 10.1097/00000658-199709000-00010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Vignon P, Dequin P-F, Renault A, et al. . Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial. Intensive Care Med 2013;39:872–80. 10.1007/s00134-013-2814-2 [DOI] [PubMed] [Google Scholar]
  • 18.Kakkos SK, Caprini JA, Geroulakos G, et al. . Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database Syst Rev 2016;9:CD005258. 10.1002/14651858.CD005258.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Pavon JM, Adam SS, Razouki ZA, et al. . Effectiveness of intermittent pneumatic compression devices for venous thromboembolism prophylaxis in high-risk surgical patients: a systematic review. J Arthroplasty 2016;31:524–32. 10.1016/j.arth.2015.09.043 [DOI] [PubMed] [Google Scholar]
  • 20.Craigie S, Tsui JF, Agarwal A, et al. . Adherence to mechanical thromboprophylaxis after surgery: a systematic review and meta-analysis. Thromb Res 2015;136:723–6. 10.1016/j.thromres.2015.06.023 [DOI] [PubMed] [Google Scholar]
  • 21.World Health Organisation Adherence to long-term therapies evidence for action. World Health Organisation, 2003. [Google Scholar]
  • 22.Jadad AR, Moore RA, Carroll D, et al. . Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12. 10.1016/0197-2456(95)00134-4 [DOI] [PubMed] [Google Scholar]
  • 23.Wells G. The Newcastle-Ottawa scale (NOS) for assessing the quality of non randomised studies in meta-analyses, 2001. Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • 24.Blaxter M. Criteria for the evaluation of qualitative research papers. Med Soc News 1996;22:68–71. [Google Scholar]
  • 25.Maxwell GL, Synan I, Hayes RP, et al. . Preference and compliance in postoperative thromboembolism prophylaxis among gynecologic oncology patients. Obstet Gynecol 2002;100:451–5. 10.1016/s0029-7844(02)02162-2 [DOI] [PubMed] [Google Scholar]
  • 26.Comerota AJ, Katz ML, White JV. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 1992;164:265–8. 10.1016/S0002-9610(05)81083-9 [DOI] [PubMed] [Google Scholar]
  • 27.Kim PS, Probeck K, Elitharp D, et al. . The staff and patient perspectives on compliance with mechanical prophylaxis for venous thromboembolism. J Vasc Surg Venous Lymphat Disord 2018;6:441–8. 10.1016/j.jvsv.2018.01.008 [DOI] [PubMed] [Google Scholar]
  • 28.Ritsema DF, Watson JM, Stiteler AP, et al. . Sequential compression devices in postoperative urologic patients: an observational trial and survey study on the influence of patient and hospital factors on compliance. BMC Urol 2013;13:20. 10.1186/1471-2490-13-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bockheim HM, McAllen KJ, Baker R, et al. . Mechanical prophylaxis to prevent venous thromboembolism in surgical patients: a prospective trial evaluating compliance. J Crit Care 2009;24:192–6. 10.1016/j.jcrc.2009.01.001 [DOI] [PubMed] [Google Scholar]
  • 30.Brady D, Raingruber B, Peterson J, et al. . The use of knee-length versus thigh-length compression stockings and sequential compression devices. Crit Care Nurs Q 2007;30:255–62. 10.1097/01.CNQ.0000278926.67562.2f [DOI] [PubMed] [Google Scholar]
  • 31.Cindolo L, Salzano L, Mirone V, et al. . Thromboprophylaxis in radical retropubic prostatectomy: efficacy and patient compliance of a dual modality. Urol Int 2009;83:12–18. 10.1159/000224861 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Elpern E, Killeen K, Patel G, et al. . The application of intermittent pneumatic compression devices for thromboprophylaxis: an observational study found frequent errors in the application of these mechanical devices in ICUs. Am J Nurs 2013;113:30–6. 10.1097/01.NAJ.0000428736.48428.10 [DOI] [PubMed] [Google Scholar]
  • 33.Gardiner DA, Kelly B. Improving rates of intermittent pneumatic compression therapy utilization. Hosp Pract 2013;41:40–7. 10.3810/hp.2013.08.1067 [DOI] [PubMed] [Google Scholar]
  • 34.Novis SJ, Havelka GE, Ostrowski D, et al. . Prevention of thromboembolic events in surgical patients through the creation and implementation of a computerized risk assessment program. J Vasc Surg 2010;51:648–54. 10.1016/j.jvs.2009.08.097 [DOI] [PubMed] [Google Scholar]
  • 35.Obi AT, Alvarez R, Reames BN, et al. . A prospective evaluation of standard versus battery-powered sequential compression devices in postsurgical patients. Am J Surg 2015;209:675–81. 10.1016/j.amjsurg.2014.06.017 [DOI] [PubMed] [Google Scholar]
  • 36.Palmerola KL, Brock CO, D'Alton ME, et al. . Compliance with mechanical venous thromboproembolism prophylaxis after cesarean delivery. J Matern Fetal Neonatal Med 2016;29:3072–5. 10.3109/14767058.2015.1118453 [DOI] [PubMed] [Google Scholar]
  • 37.Chen M, Sarnoski KA, Jacques LH, et al. . Sequential compression device compliance in pregnant women requiring antepartum admission. J Matern Fetal Neonatal Med 2019:1–7. 10.1080/14767058.2019.1623873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Cornwell EE, Chang D, Velmahos G, et al. . Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis. Am Surg 2002;68:470–3. [PubMed] [Google Scholar]
  • 39.Brady MA, Carroll AW, Cheang KI, et al. . Sequential compression device compliance in postoperative obstetrics and gynecology patients. Obstet Gynecol 2015;125:19–25. 10.1097/AOG.0000000000000554 [DOI] [PubMed] [Google Scholar]
  • 40.García-Olivares P, Guerrero JE, Keough E, et al. . Clinical factors associated with inappropriate prophylaxis of venous thromboembolic disease in critically ill patients. A single day cross-sectional study. Thromb Res 2016;143:111–7. 10.1016/j.thromres.2016.05.012 [DOI] [PubMed] [Google Scholar]
  • 41.Yamamoto T, Nakamura M, Kuroiwa M, et al. . Current prevention practice for venous thromboembolism in Japanese intensive care units. J Anesth 2013;27:931–4. 10.1007/s00540-013-1626-4 [DOI] [PubMed] [Google Scholar]
  • 42.Sobieraj-Teague M, Hirsh J, Yip G, et al. . Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high-risk neurosurgical patients. J Thromb Haemost 2012;10:229–35. 10.1111/j.1538-7836.2011.04598.x [DOI] [PubMed] [Google Scholar]
  • 43.Maffei FHdeA, Sato AC, Torggler Filho F, et al. . [Effect of the implementation of a guideline for venous thromboembolism prophylaxis in surgical patients]. Rev Assoc Med Bras 2009;55:587–92. 10.1590/s0104-42302009000500024 [DOI] [PubMed] [Google Scholar]
  • 44.Martin JL, Clark DJ, Morgan SP, et al. . A user-centred approach to requirements elicitation in medical device development: a case study from an industry perspective. Appl Ergon 2012;43:184–90. 10.1016/j.apergo.2011.05.002 [DOI] [PubMed] [Google Scholar]
  • 45.Guimicheva B, Patel JP, Roberts LN, et al. . Women’s views, adherence and experience with postnatal thromboprophylaxis. Thromb Res 2019;173:85–90. 10.1016/j.thromres.2018.11.020 [DOI] [PubMed] [Google Scholar]
  • 46.Wade R, Paton F, Woolacott N. Systematic review of patient preference and adherence to the correct use of graduated compression stockings to prevent deep vein thrombosis in surgical patients. J Adv Nurs 2017;73:336–48. 10.1111/jan.13148 [DOI] [PubMed] [Google Scholar]
  • 47.Emed JD, Morrison DR, Des Rosiers L, et al. . Definition of immobility in studies of thromboprophylaxis in hospitalized medical patients: a systematic review. J Vasc Nurs 2010;28:54–66. 10.1016/j.jvn.2009.12.003 [DOI] [PubMed] [Google Scholar]
  • 48.Cook D, Duffett M, Lauzier F, et al. . Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter survey. J Crit Care 2014;29:471.e1–e9. 10.1016/j.jcrc.2014.01.017 [DOI] [PubMed] [Google Scholar]
  • 49.Dalton K, O’Brien G, O’Mahony D, et al. . Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: a systematic review and meta-analysis. Age Ageing 2018;47:670–8. 10.1093/ageing/afy086 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjopen-2020-037036supp001.pdf (70.6KB, pdf)

Reviewer comments
Author's manuscript

Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES